Your browser doesn't support javascript.
loading
Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509).
Capdevila, Jaume; Fazio, Nicola; Lopez, Carlos; Teulé, Alexandre; Valle, Juan W; Tafuto, Salvatore; Custodio, Ana; Reed, Nicholas; Raderer, Markus; Grande, Enrique; Garcia-Carbonero, Rocio; Jimenez-Fonseca, Paula; Hernando, Jorge; Bongiovanni, Alberto; Spada, Francesca; Alonso, Vicente; Antonuzzo, Lorenzo; Spallanzani, Andrea; Berruti, Alfredo; La Casta, Adelaida; Sevilla, Isabel; Kump, Patrizia; Giuffrida, Dario; Merino, Xavier; Trejo, Lorena; Gajate, Pablo; Matos, Ignacio; Lamarca, Angela; Ibrahim, Toni.
Afiliación
  • Capdevila J; Vall Hebron University Hospital and Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Fazio N; European Institute of Oncology, Milan, IEO, IRCCS, Italy.
  • Lopez C; Marques de Valdecilla University Hospital, IDIVAL Santander, Spain.
  • Teulé A; Catalan Institute of Oncology (ICO), L'Hospitalet (Barcelona), Spain.
  • Valle JW; University of Manchester and The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Tafuto S; S.C. Sarcomi e Tumori Rari, Istituto Nazionale Tumori, IRCCS, Fondazione "G. Pascale," Naples, Italy.
  • Custodio A; La Paz University Hospital, Madrid, Spain.
  • Reed N; Gartnavel Hospital, Beatson Oncology Centre, Glasgow, Scotland.
  • Raderer M; Medical University of Vienna, Vienna, Austria.
  • Grande E; MD Anderson Cancer Center, Madrid, Spain.
  • Garcia-Carbonero R; 12 de Octubre University Hospital, Imas12, UCM, Madrid, Spain.
  • Jimenez-Fonseca P; Central de Asturias University Hospital, Oviedo, Spain.
  • Hernando J; Vall Hebron University Hospital and Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Bongiovanni A; Osteoncology and Rare Tumours Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Spada F; European Institute of Oncology, Milan, IEO, IRCCS, Italy.
  • Alonso V; Miguel Servet University Hospital, Zaragoza, Spain.
  • Antonuzzo L; Clinical Oncology Unit, AOU Careggi, Firenze, Italy and Department of Experimental and Clinical Medicine, University of Firenze, Firenze, Italy.
  • Spallanzani A; Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.
  • Berruti A; Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology, University of Brescia, ASST-Spedali Civili, Brescia, Italy.
  • La Casta A; Donosti University Hospital, Donosti, Spain.
  • Sevilla I; Investigación Clínica y Traslacional en Cáncer/Instituto de Investigaciones Biomédicas de Málaga (IBIMA)/Hospitales Universitarios Regional y Virgen de la Victoria de Málaga, Malaga, Spain.
  • Kump P; Medical University of Graz, Graz, Austria.
  • Giuffrida D; Istituto Oncologico del Mediterraneo, Catania, Italy.
  • Merino X; Vall Hebron University Hospital and Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Trejo L; Vall Hebron University Hospital and Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Gajate P; Ramon y Cajal University Hospital, Madrid.
  • Matos I; Vall Hebron University Hospital and Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Lamarca A; University of Manchester and The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Ibrahim T; Osteoncology and Rare Tumours Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
J Clin Oncol ; 39(20): 2304-2312, 2021 07 10.
Article en En | MEDLINE | ID: mdl-33945297
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 3_diarrhea / 4_diarrhoeal_infections / 6_endocrine_disorders / 6_pancreatic_cancer Asunto principal: Neoplasias Pancreáticas / Compuestos de Fenilurea / Quinolinas / Tumores Neuroendocrinos / Inhibidores de Proteínas Quinasas / Neoplasias Gastrointestinales / Antineoplásicos Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Clin Oncol Año: 2021 Tipo del documento: Article País de afiliación: España
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 3_diarrhea / 4_diarrhoeal_infections / 6_endocrine_disorders / 6_pancreatic_cancer Asunto principal: Neoplasias Pancreáticas / Compuestos de Fenilurea / Quinolinas / Tumores Neuroendocrinos / Inhibidores de Proteínas Quinasas / Neoplasias Gastrointestinales / Antineoplásicos Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Clin Oncol Año: 2021 Tipo del documento: Article País de afiliación: España